Page 7 - Haematologica May 2020

1379 Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription
Jennifer Edelmann et al.
Plasma Cell Disorders
1391 IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification Phaik Ju Teoh et al.
1405 Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria Faye A. Sharpley et al.
Platelet Biology & its Disorders
1414 Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice Nathan Eaton et al.
Hemostasis
1424 The contact system proteases play disparate roles in streptococcal sepsis Juliane Köhler et al.
Coagulation & its Disorders
1436 Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis
Aurélien Delluc et al.
1443 Relationship between factor VIII activity, bleeds and individual characteristics in severe hemophilia A patients João A. Abrantes et al.
Stem Cell Transplantation
1454 Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation Aleksandar Radujkovic et al.
Errata Corrige
Non-Hodgkin Lymphoma
1465 Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression
John F. Seymour et al.
Letters to the Editor
Letters are available online only at www.haematologica.org/content/105/5.toc
e206 Functional assessment of glucocerebrosidase modulator efficacy in primary patient-derived macrophages is essential for drug develop- ment and patient stratification
Natalie J. Welsh et al. http://www.haematologica.org/content/105/5/e206
e210 Ruxolitinib for refractory/relapsed hemophagocytic lymphohistiocytosis Jingshi Wang et al.
http://www.haematologica.org/content/105/5/e210
e213 5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respec- tively
Daniel Gackowski et al. http://www.haematologica.org/content/105/5/e213
haematologica Journal of the Ferrata Storti Foundation
Chronic Lymphocytic Leukemia
Haematologica 2020; vol. 105 no. 5 - May 2020 http://www.haematologica.org/